Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation

JA Tanner, M Novalen, P Jatlow, MA Huestis… - … Biomarkers & Prevention, 2015 - AACR
Background: The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-3′-hydroxycotinine (3HC). The nicotine metabolite ratio …
被引用次数：78 相关文章

Nicotine metabolite ratio (3-Hydroxycotinine/Cotinine) in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation

JA Tanner, M Novalen, P Jatlow… - Cancer Epidemiology …, 2015 - experts.umn.edu
Background: The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-30-hydroxycotinine (3HC). The nicotine metabolite ratio …

Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation

JA Tanner, M Novalen, P Jatlow… - … & prevention: a …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-3'-hydroxycotinine (3HC). The nicotine metabolite ratio …

Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation.

JA Tanner, M Novalen, P Jatlow… - Cancer Epidemiology …, 2015 - dial.uclouvain.be
(eng) BACKGROUND: The highly genetically variable enzyme CYP2A6 metabolizes
nicotine to cotinine (COT) and COT to trans-3'-hydroxycotinine (3HC). The nicotine …
[PDF] academia.edu

[PDF][PDF] Nicotine Metabolite Ratio (3-hydroxycotinine/cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical …

JA Tanner, M Novalen, P Jatlow, MA Huestis… - Cancer Epidemiol …, 2015 - academia.edu
Background—The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-3′-hydroxycotinine (3HC). The nicotine metabolite ratio …

Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.

JA Tanner, M Novalen, P Jatlow… - … & Prevention: a …, 2015 - europepmc.org
Background The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-3'-hydroxycotinine (3HC). The nicotine metabolite ratio …
[PDF] researchgate.net

[PDF][PDF] Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical …

JA Tanner, M Novalen, P Jatlow, MA Huestis… - researchgate.net
Background: The highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-30-hydroxycotinine (3HC). The nicotine metabolite ratio …

Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation

JA Tanner, M Novalen, P Jatlow… - Cancer Epidemiology …, 2015 - escholarship.org
BackgroundThe highly genetically variable enzyme CYP2A6 metabolizes nicotine to
cotinine (COT) and COT to trans-3'-hydroxycotinine (3HC). The nicotine metabolite ratio …

[引用][C] Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical …

JA Tanner, M Novalen, P Jatlow… - Cancer …, 2015 - researchportal.helsinki.fi
Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different
Analytical Methods and Laboratories: Implications for Clinical Implementation — University of …

[引用][C] Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical …

JA Tanner, M Novalen, P Jatlow, MA Huestis… - 2015 - julkari.fi
Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical
Methods and Laboratories: Implications for Clinical Implementation Hyppää sisältöön Näytä/piilota …